PsiQuantum a un plan pour faire un ordinateur quantique massif à partir de la lumière

PsiQuantum, a quantum computing startup founded in 2016 by four physicists from UK universities, has unveiled a bold plan to create a massive quantum computer powered by photons, particles of light. The system, designed to revolutionize fields ranging from pharmaceuticals to artificial intelligence, is set to operate within a facility resembling a hybrid of a data center and an ice cream factory. This unique setup includes approximately 100 stainless-steel cabinets, each standing around six feet tall, cooled by a continuous supply of liquid helium to maintain temperatures just above absolute zero. Within these cabinets, hundreds of quantum chips will host thousands of photons navigating complex networks of optical switches and beam splitters. Precise tracking of these photons is crucial, as their final positions could provide solutions to problems that traditional computers might take millions of years to resolve. The concept of quantum computing traces back to physicist Richard Feynman’s 1981 proposal, envisioning machines that leverage the peculiar properties of quantum particles. Unlike classical bits, which exist in binary states of 1 or 0, quantum bits, or qubits, can occupy multiple states simultaneously. When combined, these qubits can perform calculations far beyond the capabilities of today’s supercomputers. However, current quantum prototypes remain limited in scale and prone to errors, making them unsuitable for practical applications. PsiQuantum’s ambitions stand out in a competitive landscape filled with ambitious startups backed by substantial capital. The company’s goal is to deliver a fully functional, large-scale quantum computer that can tackle real-world challenges efficiently. One of its key targets is improving drug discovery by accurately modeling the behavior of cytochrome P450 enzymes, which play a critical role in metabolizing medications. According to Philipp Ernst, vice president of quantum applications at PsiQuantum, estimating the impact of these enzymes on a specific drug currently takes over a decade using conventional methods. The company aims to reduce this time dramatically, potentially cutting it down to just four minutes. To achieve this, PsiQuantum is leveraging existing semiconductor manufacturing facilities to produce its quantum chips. This approach allows the company to integrate its technology into established production lines, enhancing scalability and reliability. The project has gained significant traction, evidenced by a $1 billion funding round last year and the commencement of construction on a state-of-the-art facility in Chicago, in collaboration with local governments. An additional site in Australia is under development, with plans to begin operations by 2027. PsiQuantum is among only two firms, alongside Microsoft, that have reached the third stage of a rigorous government assessment aimed at identifying promising quantum computing ventures. Despite the enthusiasm surrounding PsiQuantum’s progress, evaluating the success of its endeavor presents unique challenges. Quantum computing advancements are often incremental, difficult to observe externally, and hard to validate without direct access to the underlying technology. As the company nears its pivotal moment of demonstration, the coming months will reveal whether years of secretive research and billions in investment will result in a transformative quantum computer or fall short of expectations. The first signs of success or failure may emerge as early as next year.